臨床試驗

MagDI Italian Study

NCT：NCT06613711 · COMPLETED

NCT IDNCT06613711

狀態COMPLETED

開始日期2024-09-20

完成時間2026-02-24

SponsorGT Metabolic Solutions, Inc. (INDUSTRY)

First posted2024-09-26

Last updated2026-05-20

簡要摘要

The objective of the MagDI Italy Study is to evaluate the feasibility / performance, safety, and initial efficacy of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion (e.g., one example of a small bowel clinical procedure requiring a side-to-side anastomosis).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。